Description
Provider of direct access brokerage and equity trading services. The company offers a range of technological capabilities that create a compelling opportunity to accelerate revenue growth in business and add key service offerings to meet the evolving needs of their institutional and wealth management clients and providing them the best possible access to North American and international exchanges.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 06-Jun-2018 | Completed | Generating Revenue | |||
1. Later Stage VC | 01-Dec-2008 | Completed | Generating Revenue |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jean-Francois Sabourin | Chief Executive Officer & President |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Tactico | Venture Capital | Minority | 000 0000 | 000000 0 |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 0000 | 10-May-2018 | 0000 | 00.000 | Drug Discovery |
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00000000 000000000 | 10-May-2018 | 0000 | 00.000 | Completed |
|